![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Japan's Eisai Establishes New Subsidiary in Italy
Japan's Eisai Establishes New Subsidiary in Italy
Japanese drugmaker Eisai has set up a new subsidiary in Italy, enhancing its existing European presence in the UK, France, Germany and Spain. The new wholly-owned company, to be known as Eisai Srl, will market the Japanese firm's anti-epileptic drug Zonegran (candesartan), for which the company has submitted an EMEA marketing application. A submission for another anti-epileptic, rufinamide, is to be filed later in the year.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
18Jul
-
21Oct